Previous studies in lymphoma, lung and liver cancers have also reported changes in lipid composition, signaling and metabolism with MYC amplification [47–49], suggesting that the relationship between MYC and lipids is not restricted to tumors developed from neural derived tissue. Here, MYC is linked to liver cancer.